| |
| |
| Exchange: |
|
| Security
Type: |
|
| Shares
Out: |
259,770,000 |
| Market
Cap: |
1.27(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.5305 - $10.22 |
|
| Level
I Sector: |
|
| Level
II Sector: |
|
| Level
III Sector: |
|
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile 23andMe Holding is a newly blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
823,779 |
| Total Sell Value |
$0 |
$0 |
$0 |
$737,691 |
| Total People Sold |
0 |
0 |
0 |
2 |
| Total Sell Transactions |
0 |
0 |
0 |
22 |
| End Date |
2025-04-03 |
2024-12-31 |
2024-07-02 |
2023-07-03 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Wojcicki Anne |
Director |
– • • |
2025-06-09 |
4 |
A |
$0.00 |
$0 |
I/I |
4,931,692 |
4,931,692 |
|
- |
|
| Selsavage Joseph Anthony |
Interim CEO, CFO & CAO |
• – – |
2025-05-20 |
4 |
D |
$3.36 |
$17,045 |
D/D |
(5,073) |
91,395 |
|
- |
|
| Selsavage Joseph Anthony |
Chief Financial & Actng Ofcr |
• – – |
2025-02-20 |
4 |
D |
$2.74 |
$15,492 |
D/D |
(5,654) |
96,468 |
|
- |
|
| Selsavage Joseph Anthony |
Chief Financial & Actng Ofcr |
• – – |
2024-11-20 |
4 |
D |
$3.15 |
$16,629 |
D/D |
(5,279) |
102,122 |
|
- |
|
| Montgomery Rice Valerie Md |
Director |
– • – |
2024-08-26 |
4 |
A |
$0.00 |
$65,000 |
D/D |
853,037 |
1,207,918 |
|
- |
|
| Hernandez Sandra R Md |
Director |
– • – |
2024-08-26 |
4 |
A |
$0.00 |
$50,000 |
D/D |
808,140 |
1,203,204 |
|
- |
|
| Botha Roelof |
Director |
– • – |
2024-08-26 |
4 |
A |
$0.33 |
$60,000 |
I/I |
179,586 |
483,526 |
|
- |
|
| Botha Roelof |
Director |
– • – |
2024-08-26 |
4 |
A |
$0.00 |
$0 |
D/D |
658,485 |
658,485 |
|
- |
|
| Chung Patrick S |
Director |
– • – |
2024-08-26 |
4 |
A |
$0.00 |
$67,500 |
D/D |
860,520 |
1,161,941 |
|
- |
|
| Scheller Richard H |
Director |
– • – |
2024-08-26 |
4 |
A |
$0.00 |
$0 |
D/D |
658,485 |
895,961 |
|
- |
|
| Mohan Neal |
Director |
– • – |
2024-08-26 |
4 |
A |
$0.00 |
$0 |
D/D |
658,485 |
904,291 |
|
- |
|
| Taylor Peter J. |
Director |
– • – |
2024-08-26 |
4 |
A |
$0.00 |
$0 |
D/D |
658,485 |
981,217 |
|
- |
|
| Richards William G |
Head of Therapeutics Discovery |
• – – |
2024-08-20 |
4 |
D |
$0.36 |
$20,393 |
D/D |
(57,365) |
573,069 |
|
- |
|
| Selsavage Joseph Anthony |
Chief Financial & Actng Ofcr |
• – – |
2024-08-20 |
4 |
D |
$0.36 |
$39,243 |
D/D |
(110,388) |
2,148,002 |
|
- |
|
| Taylor Peter J. |
Director |
– • – |
2024-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
57,515 |
322,732 |
|
- |
|
| Montgomery Rice Valerie Md |
Director |
– • – |
2024-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
15,337 |
354,881 |
|
- |
|
| Hernandez Sandra R Md |
Director |
– • – |
2024-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
57,515 |
395,064 |
|
- |
|
| Selsavage Joseph Anthony |
Chief Financial & Actng Ofcr |
• – – |
2024-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
1,000,000 |
2,258,390 |
|
- |
|
| Selsavage Joseph Anthony |
Interim CFO |
• – – |
2024-05-20 |
4 |
D |
$0.55 |
$20,177 |
D/D |
(36,913) |
1,258,390 |
|
- |
|
| Hibbs Kathy L |
Chief Administrative Officer |
• – – |
2024-05-20 |
4 |
D |
$0.55 |
$19,285 |
D/D |
(35,282) |
1,217,033 |
|
- |
|
| Richards William G |
Head of Therapeutics Discovery |
• – – |
2024-05-20 |
4 |
D |
$0.55 |
$8,804 |
D/D |
(16,106) |
630,434 |
|
- |
|
| Hibbs Kathy L |
Chief Administrative Officer |
• – – |
2024-05-02 |
4 |
AS |
$0.49 |
$19,048 |
D/D |
(38,551) |
1,252,315 |
|
-35% |
|
| Hibbs Kathy L |
Chief Administrative Officer |
• – – |
2024-05-02 |
4 |
OE |
$0.42 |
$16,191 |
D/D |
38,551 |
1,290,866 |
|
- |
|
| Hibbs Kathy L |
Chief Administrative Officer |
• – – |
2024-04-18 |
4 |
AS |
$0.47 |
$18,148 |
D/D |
(38,548) |
1,252,315 |
|
-39% |
|
| Hibbs Kathy L |
Chief Administrative Officer |
• – – |
2024-04-18 |
4 |
OE |
$0.42 |
$16,190 |
D/D |
38,548 |
1,290,863 |
|
- |
|
149 Records found
|
|
Page 1 of 6 |
|
|
0.02 (0.51%) 
